Effect of IV Lidocaine Infusions on Pain
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 71
- 试验地点
- 1
- 主要终点
- Present Pain Intensity
研究概览
简要总结
Our goals for this study involve using intravenous lidocaine as it is normally used in the Stanford Pain Management Center to assess the effect of intravenous lidocaine on chronic pain. Studies have been done determining the efficacy of intravenous lidocaine for treating pain but little research has been done to determine the effects of an intravenous lidocaine infusion on the different components of the pain experience. Our study will incorporate pain quality measures both before and during the infusions of lidocaine to determine changes in present pain intensity.
详细描述
Each patient will receive an intravenous infusion of lidocaine. Drug will be infused using a computer-controlled paradigm. This paradigm allows increasing plasma concentrations in a step-wise manner, keeping the concentration during each infusion step constant. Plasma concentrations will be increased gradually from 0 to 5 ug/ml in a method at the discretion of the medical team. This will be conducted according to standard medical practice for the infusion and the study procedures will not affect the infusion paradigm. Total infusion time is approximately 1-2 hours. During the course of the study, the primary outcome measure was changed from blood oxygenation level dependent (BOLD) signal to pain intensity.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •subjects between the ages of 18 and 100 years for clinical component; subjects between the ages of 18 and 70 for the MRI component
- •meets the study criteria of chronic pain of either peripheral or central origin
- •male or a non-pregnant, non-lactating female. If females are of reproductive potential (i.e., not surgically sterilized and/or not post menopausal), they must be practicing an accepted method of birth control, agree to a urine pregnancy test at the start of each study session (for patient scheduled through the clinic, this has already been addressed by the recommending physician)
- •is not currently on a sodium channel blocking agent, anticonvulsant, or tricyclic antidepressant,
- •must be able to comply with any other study requirements and complete experimental tasks
- •have no reported substance abuse within the past six months;
排除标准
- •subject is lactating or pregnant;
- •subject suffers from clinically significant cardiac, pulmonary, renal or liver disease;
- •subject allergic to lidocaine.
- •MRI Component: any metal objects (especially surgical clips), devices, or implants or any other MRI contraindication
研究组 & 干预措施
Lidocaine infusion
Each participant will receive an intravenous infusion of lidocaine. Plasma concentrations will be increased gradually from 0-5 µg/ml.
干预措施: Intravenous lidocaine (Drug)
结局指标
主要结局
Present Pain Intensity
时间窗: Patients completed the VAS of present pain intensity immediately before and immediately after placebo and during each infusion level
Present pain intensity was measured using the visual analog scale (VAS). This is scored between 0 (no pain) to 10 (worst possible pain).
次要结局
未报告次要终点
研究者
Sean Mackey
Assistant Professor
Stanford University